Answers are grounded in this paper and cite their sources.
Scoping review synthesizes evidence on plasmid-mediated antimicrobial resistance in the human microbiome, indicating critical implications for clinical interventions.
Background: AMR remains a critical global health threat, yet pathogen-focused surveillance underestimates the commensal human microbiome as a resistance gene reservoir. Evidence linking plasmid persistence, stress-associated mobilization, and clinical relevance remains fragmented. Objective: This scoping review synthesized evidence on plasmid persistence mechanisms, antibiotic- and stressor-associated horizontal gene transfer (HGT), and clinical or translational implications of microbiome-associated AMR. Methods: Following PRISMA-ScR guidelines, five databases (PubMed/MEDLINE, Embase, Web of Science, Scopus, and Global Health) were searched for English-language studies published between January 2010 and December 2025. From 1,200 records identified, 223 unique records were screened after duplicate removal, and 35 met the inclusion criteria. Data were extracted on plasmid maintenance, mobilization pathways, clinical relevance, and translational approaches. Results: Sixteen studies on plasmid persistence showed that maintenance may be supported by host–plasmid co-adaptation, compensatory evolution, regulatory remodeling, epistatic interactions, and stability systems. Eight studies on stressor-associated mobilization indicated that HGT may be influenced by SOS responses, metabolic disruption, redox imbalance, antibiotic-specific regulatory effects, and selection-driven genetic exchange. Eleven clinical or translational studies highlighted underdetection of plasmid-mediated AMR transmission and early evidence for microbiome-based and anti-plasmid strategies, including fecal microbiota transplantation, CRISPR-based targeting, conjugation inhibition, and RecA-targeted approaches. Conclusion: Plasmid-mediated AMR in the human microbiome is shaped by persistence dynamics, stress-associated mobilization, and clinical selective pressures. Plasmid-resolved surveillance, standardized HGT detection, longitudinal studies, and validated microbiome-informed interventions are needed to strengthen AMR mitigation.
No takes yet. Share an insight, caveat, or question.
Olayiwola et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: